4.95
price up icon5.77%   0.27
after-market Handel nachbörslich: 4.99 0.04 +0.81%
loading
Schlusskurs vom Vortag:
$4.68
Offen:
$4.54
24-Stunden-Volumen:
992.04K
Relative Volume:
2.69
Marktkapitalisierung:
$240.24M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-54.19M
KGV:
-1.9186
EPS:
-2.58
Netto-Cashflow:
$-37.34M
1W Leistung:
-1.79%
1M Leistung:
-2.75%
6M Leistung:
-22.41%
1J Leistung:
-38.51%
1-Tages-Spanne:
Value
$4.5101
$4.985
1-Wochen-Bereich:
Value
$4.4205
$5.1399
52-Wochen-Spanne:
Value
$3.05
$8.45

Abeona Therapeutics Inc Stock (ABEO) Company Profile

Name
Firmenname
Abeona Therapeutics Inc
Name
Telefon
646-813-4701
Name
Adresse
6555 CARNEGIE AVE, 4TH FLOOR, CLEVELAND, NY
Name
Mitarbeiter
136
Name
Twitter
@abeonabio
Name
Nächster Verdiensttermin
2024-12-11
Name
Neueste SEC-Einreichungen
Name
ABEO's Discussions on Twitter

Vergleichen Sie ABEO mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
ABEO
Abeona Therapeutics Inc
4.95 240.24M 0 -54.19M -37.34M -2.58
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
484.01 124.29B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
610.64 68.39B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
590.06 35.99B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
262.16 33.93B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
264.32 28.47B 3.81B -644.79M -669.77M -6.24

Abeona Therapeutics Inc Stock (ABEO) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-03-05 Eingeleitet Oppenheimer Outperform
2024-07-03 Eingeleitet H.C. Wainwright Buy
2024-05-30 Eingeleitet Stifel Buy
2020-11-11 Hochstufung Cantor Fitzgerald Neutral → Overweight
2020-09-18 Eingeleitet B. Riley FBR Buy
2020-02-10 Eingeleitet SVB Leerink Outperform
2019-12-10 Fortgesetzt Cantor Fitzgerald Neutral
2019-08-15 Herabstufung Maxim Group Buy → Hold
2019-08-12 Herabstufung Cantor Fitzgerald Overweight → Neutral
2019-07-26 Herabstufung Mizuho Buy → Neutral
2019-06-27 Eingeleitet Mizuho Buy
2018-10-12 Eingeleitet Mizuho Buy
2018-06-05 Eingeleitet Seaport Global Securities Buy
2017-11-08 Eingeleitet SunTrust Buy
2017-10-16 Bestätigt H.C. Wainwright Buy
2017-10-11 Bestätigt Cantor Fitzgerald Overweight
2017-10-10 Eingeleitet Citigroup Buy
2017-10-05 Bestätigt Maxim Group Buy
2017-09-15 Eingeleitet RBC Capital Mkts Outperform
2017-07-18 Bestätigt Maxim Group Buy
2017-06-22 Fortgesetzt Jefferies Buy
2017-01-06 Eingeleitet Jefferies Buy
2016-09-29 Bestätigt Maxim Group Buy
Alle ansehen

Abeona Therapeutics Inc Aktie (ABEO) Neueste Nachrichten

pulisher
Apr 02, 2025

Breakeven On The Horizon For Abeona Therapeutics Inc. (NASDAQ:ABEO) - simplywall.st

Apr 02, 2025
pulisher
Apr 01, 2025

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Apr 01, 2025
pulisher
Apr 01, 2025

Abeona Therapeutics Expands Team with Strategic Stock Grants for Key New Talent - Stock Titan

Apr 01, 2025
pulisher
Mar 31, 2025

Abeona Therapeutics CEO sells shares worth $119,500 - Investing.com India

Mar 31, 2025
pulisher
Mar 31, 2025

Abeona Therapeutics CEO sells shares worth $119,500 By Investing.com - Investing.com Australia

Mar 31, 2025
pulisher
Mar 28, 2025

Abeona Therapeutics (NASDAQ:ABEO) Upgraded by StockNews.com to Hold Rating - MarketBeat

Mar 28, 2025
pulisher
Mar 28, 2025

What is Zacks Small Cap’s Estimate for ABEO Q3 Earnings? - Defense World

Mar 28, 2025
pulisher
Mar 27, 2025

What is Zacks Small Cap’s Forecast for ABEO Q1 Earnings? - Defense World

Mar 27, 2025
pulisher
Mar 27, 2025

Equities Analysts Set Expectations for ABEO Q1 Earnings - Defense World

Mar 27, 2025
pulisher
Mar 26, 2025

Trend Tracker for (ABEO) - news.stocktradersdaily.com

Mar 26, 2025
pulisher
Mar 26, 2025

What is HC Wainwright’s Forecast for ABEO Q1 Earnings? - Defense World

Mar 26, 2025
pulisher
Mar 25, 2025

Abeona Therapeutics (NASDAQ:ABEO) Given Buy Rating at HC Wainwright - Defense World

Mar 25, 2025
pulisher
Mar 25, 2025

Abeona Therapeutics (NASDAQ:ABEO) Upgraded to Hold at StockNews.com - Defense World

Mar 25, 2025
pulisher
Mar 24, 2025

Abeona Therapeutics: Positive Outlook Amid FDA Hopes - MSN

Mar 24, 2025
pulisher
Mar 22, 2025

Abeona Therapeutics Inc. (NASDAQ:ABEO) Q4 2024 Earnings Call Transcript - Insider Monkey

Mar 22, 2025
pulisher
Mar 21, 2025

Abeona planning potential US launch of pz-cel to treat RDEB - Epidermolysis Bullosa News

Mar 21, 2025
pulisher
Mar 21, 2025

Abeona Therapeutics Inc (ABEO) Q4 2024 Earnings Call Highlights: Strategic Advancements and ... - Yahoo Finance

Mar 21, 2025
pulisher
Mar 21, 2025

Abeona Therapeutics Inc (ABEO) Q4 2024 Earnings Call Highlights: Strategic Advancements and ... By GuruFocus - Investing.com Canada

Mar 21, 2025
pulisher
Mar 21, 2025

Abeona Therapeutics Reports 2024 Financial Results - TipRanks

Mar 21, 2025
pulisher
Mar 20, 2025

Earnings call transcript: Abeona Therapeutics reports Q4 2024 EPS beat - Investing.com India

Mar 20, 2025
pulisher
Mar 20, 2025

Earnings call transcript: Abeona Therapeutics reports Q4 2024 EPS beat By Investing.com - Investing.com UK

Mar 20, 2025
pulisher
Mar 20, 2025

Abeona Therapeutics targets $2B revenue potential for pz-cel amid U.S. launch preparations - MSN

Mar 20, 2025
pulisher
Mar 20, 2025

Oppenheimer maintains Abeona Therapeutics Outperform rating - Investing.com India

Mar 20, 2025
pulisher
Mar 20, 2025

Abeona Therapeutics® Reports Full Year 2024 Financial - GlobeNewswire

Mar 20, 2025
pulisher
Mar 20, 2025

Abeona Therapeutics Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 20, 2025
pulisher
Mar 20, 2025

ABEONA THERAPEUTICS INC. SEC 10-K Report - TradingView

Mar 20, 2025
pulisher
Mar 20, 2025

Abeona Therapeutics® Reports Full Year 2024 Financial Results, Provides Pz-cel Regulatory - Bluefield Daily Telegraph

Mar 20, 2025
pulisher
Mar 20, 2025

Abeona Strengthens to $98M Cash Position as FDA Decision for Pz-cel Approaches - StockTitan

Mar 20, 2025
pulisher
Mar 16, 2025

(ABEO) On The My Stocks Page - news.stocktradersdaily.com

Mar 16, 2025
pulisher
Mar 14, 2025

Abeona Therapeutics Inc expected to post a loss of 35 cents a shareEarnings Preview - TradingView

Mar 14, 2025
pulisher
Mar 13, 2025

Dystrophic Epidermolysis Bullosa Market Forecasted to Surge - openPR.com

Mar 13, 2025
pulisher
Mar 10, 2025

Abeona Therapeutics at Leerink’s Global Healthcare Conference: Launch Plans for PZcell - Investing.com Canada

Mar 10, 2025
pulisher
Mar 10, 2025

Abeona Therapeutics (ABEO) Projected to Post Earnings on Monday - Defense World

Mar 10, 2025
pulisher
Mar 07, 2025

Abeona Therapeutics (NASDAQ:ABEO) Coverage Initiated at Oppenheimer - Defense World

Mar 07, 2025
pulisher
Mar 06, 2025

Oppenheimer Initiates Coverage of Abeona Therapeutics (ABEO) with Outperform Recommendation - MSN

Mar 06, 2025
pulisher
Mar 05, 2025

This Krystal Biotech Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday - Benzinga

Mar 05, 2025
pulisher
Mar 05, 2025

Oppenheimer Initiates Coverage of Abeona Therapeutics (LSE:0H7R) with Outperform Recommendation - Nasdaq

Mar 05, 2025
pulisher
Mar 05, 2025

Trading (ABEO) With Integrated Risk Controls - Stock Traders Daily

Mar 05, 2025
pulisher
Mar 04, 2025

Abeona Therapeutics® to Present at the Leerink Partners Global Healthcare Conference - GlobeNewswire

Mar 04, 2025
pulisher
Mar 04, 2025

When Abeona Therapeutics Takes the Stage: CEO's Upcoming Leerink Conference Presentation - StockTitan

Mar 04, 2025
pulisher
Mar 04, 2025

Abeona Therapeutics announces new employee inducement grants - Yahoo Finance

Mar 04, 2025
pulisher
Mar 03, 2025

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - Marketscreener.com

Mar 03, 2025
pulisher
Mar 03, 2025

How Abeona Therapeutics Is Structuring Compensation to Attract New Talent - StockTitan

Mar 03, 2025
pulisher
Feb 27, 2025

Abeona Therapeutics Insider Stock Sales Prove Timely As Market Valuation Descends To US$232m - Simply Wall St

Feb 27, 2025
pulisher
Feb 25, 2025

StockNews.com Downgrades Abeona Therapeutics (NASDAQ:ABEO) to Sell - MarketBeat

Feb 25, 2025
pulisher
Feb 22, 2025

How the (ABEO) price action is used to our Advantage - Stock Traders Daily

Feb 22, 2025
pulisher
Feb 21, 2025

Cell and Gene Therapies in Rare Disorders Market to Skyrocket Across the 7MM During the Forecast Period (2025–2034) | DelveInsight - GlobeNewswire Inc.

Feb 21, 2025
pulisher
Feb 21, 2025

Abeona Therapeutics Inc (NASDAQ:ABEO) Short Interest Down 6.8% in January - MarketBeat

Feb 21, 2025
pulisher
Feb 20, 2025

HC Wainwright Reaffirms "Buy" Rating for Abeona Therapeutics (NASDAQ:ABEO) - MarketBeat

Feb 20, 2025
pulisher
Feb 20, 2025

Abeona Therapeutics’ (ABEO) Buy Rating Reaffirmed at HC Wainwright - Defense World

Feb 20, 2025
pulisher
Feb 18, 2025

Epidermolysis Bullosa Market Expected to rise, 2034 | Amryt - openPR

Feb 18, 2025

Finanzdaten der Abeona Therapeutics Inc-Aktie (ABEO)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$67.48
price down icon 1.23%
$73.33
price down icon 0.15%
$31.79
price up icon 1.63%
$18.91
price down icon 7.58%
$92.01
price down icon 1.40%
biotechnology ONC
$264.32
price down icon 3.81%
Kapitalisierung:     |  Volumen (24h):